BI

BioPlus Co., Ltd

Develops & manufactures HA-based biomaterials & medical devices for aesthetics & medical sectors.

099430 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
경기도 성남시 중원구 사기막골로45번길 14, 18층 제에이-1801,1802호(상대원동, 성남 우림라이온스밸리2차, 성남시
Sector:
Manufacturing
Industry:
Manufacture of medical and dental instruments and supplies

Description

BioPlus Co., Ltd. is a biotechnology company specializing in the research, development, and manufacturing of biomaterials and medical devices. Founded in 2003, the company's core competency is its proprietary MDM® Technology, a platform for developing advanced applications of hyaluronic acid (HA). Its product portfolio includes a range of HA-based dermal fillers, anti-adhesion agents, biomaterial breast implants, and artificial cartilage. BioPlus focuses on providing innovative solutions for the aesthetics and medical sectors, creating bio-goods that promote beauty and health.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-19 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.8 KB
2025-09-19 00:00
Transaction in Own Shares
자기주식처분결과보고서
Korean 21.6 KB
2025-09-18 00:00
Transaction in Own Shares
주요사항보고서(자기주식처분결정)
Korean 31.5 KB
2025-09-02 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 109.1 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.6 MB
2025-05-14 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.5 MB
2025-04-30 00:00
Regulatory News Service
소속부변경
Korean 3.6 KB
2025-03-28 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 24.1 KB
2025-03-20 00:00
Audit Report / Information
감사보고서제출
Korean 28.2 KB
2025-03-20 00:00
Audit Report / Information
사업보고서 (2024.12)
Korean 622.6 KB

Automate Your Workflow. Get a real-time feed of all BioPlus Co., Ltd filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for BioPlus Co., Ltd via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
TISSUE REGENIX GROUP PLC Logo
Develops regenerative biological products for orthopaedic and dental markets.
United Kingdom TRX
T&R Biofab Co., Ltd Logo
Develops 3D bioprinted scaffolds for tissue repair in orthopedics, surgery, and dentistry.
South Korea 246710
Developing disruptive, pre-approval technologies for the spinal stabilization market.
United Kingdom N/A
Ulisse Biomed Logo
Provides a portable platform for rapid point-of-need genetic analysis and diagnostics.
Italy UBM
UXN Co., Ltd. Logo
Develops advanced continuous glucose monitoring systems and sensors for diabetes management.
South Korea 337840
Viromed Medical Logo
Develops cold plasma tech for infection control, wound care, and air disinfection for healthcare.
Germany VMED
Vitrolife Logo
A global provider of medical devices and genetic testing services for IVF clinics to improve outcomes.
Sweden VITR
Vitruvia Medical AG Logo
Circular economy provider for robotic surgery instruments for European clinics and hospitals.
Germany 991
Wonbiogen Co.,Ltd. Logo
Develops and manufactures advanced wound care solutions and medical materials.
South Korea 307280
Xvivo Perfusion Logo
Develops ex-vivo machine perfusion systems to improve organ viability for transplantation.
Sweden XVIVO

Talk to a Data Expert

Have a question? We'll get back to you promptly.